Fundz

Linus Biotechnology reported raising $8 Million in an initial SEC Form D filing, from an offering of $8 Million

PRIVATEMay 26, 2023

Amount Raised

$8 Million

$8 Million sold, per SEC Form D (first sale May 19, 2023)

Round Type

Venture

New RochelleBiotechnologyHealth Care

Quick answer

LinusBio raised $8 Million in a funding round, dated May 19, 2023. LinusBio is based in New Rochelle, New York, United States.

How much did LinusBio raise?
LinusBio raised $8 Million in a funding round on May 19, 2023.
What does LinusBio do?
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company.
Where is LinusBio based and how big is it?
LinusBio is based in New Rochelle, New York, United States.
Who are the decision-makers at LinusBio?
Fundz holds 1 contact at LinusBio, including the Co-founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as LinusBio that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $1.7M (Seed) on June 30, 2023.
  • CurvaFix raised $24M on June 29, 2023.
  • Evommune raised an undisclosed amount (Series B) on June 28, 2023.
  • Actym Therapeutics raised $11M on June 28, 2023.
  • Gleamer SAS raised $30M (Funding Round) on June 28, 2023.
  • K36 Therapeutics raised $70M (Series B) on June 28, 2023.

Who to call at LinusBio, and when

A new round usually means LinusBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LinusBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LinusBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LinusBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LinusBio

Location

New Rochelle, New York, United States

About

Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LinusBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsManish A., Co-founder & CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for LinusBio's next move

See what Strategic adds

LinusBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.